Clinical Trials · NCT02717858
A Trial to Assess the Effects of Liraglutide on Gallbladder Emptying in Overweight and Obese Subjects.
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 52
- Start date
- Mar 2016
- Locations
- 1 site, Denmark
- Primary endpoint
- Maximum postprandial gallbladder ejection fraction (GBEFmax)